HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Figures All Versions of this Article: 2005-0463v1 2005-0463v2 24/4/1121    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Burns, T. C. Articles by Verfaillie, C. M. Search for Related Content PubMed PubMed Citation Articles by Burns, T. C. Articles by Verfaillie, C. M.

TISSUE-SPECIFIC STEM CELLS

Thymidine Analogs Are Transferred from Prelabeled Donor to Host Cells in the Central Nervous System After Transplantation: A Word of Caution

^a Stem Cell Institute,
^b Department of Neurosurgery,
^c Graduate Program in Neuroscience, University of Minnesota, Minneapolis, Minnesota, USA;
^d Clínica Universitaria, Universidad de Navarra, Pamplona, Spain;
^e Department of Cell Biology, Instituto Cavanilles and Centro de Investigacion Principe Felipe, University of Valencia, Valencia, Spain;
^f Department of Neuroscience, University of Minnesota, Minneapolis, Minnesota, USA;
^g Division of Neurosciences, Centre for Applied Medical Research, Pamplona, Spain

Key Words. Adult bone marrow stem cells • Label • Bromodeoxyuridine • Thymidine analog • Control • Transplantation • Neural differentiation • In vivo tracking

Correspondence: Catherine M. Verfaillie, M.D., Stem Cell Institute, Department of Medicine, University of Minnesota, 420 Delaware Street, Minneapolis, Minnesota 55455, USA. Telephone: 612-625-0602; Fax: 612-624-2436; e-mail: verfa001{at}umn.edu

Received on September 22, 2005; accepted for publication on December 5, 2005.

Thymidine analogs, including bromodeoxyuridine, chlorodeoxyuridine, iododeoxyuridine, and tritiated thymidine, label dividing cells by incorporating into DNA during S phase of cell division and are widely employed to identify cells transplanted into the central nervous system. However, the potential for transfer of thymidine analogs from grafted cells to dividing host cells has not been thoroughly tested. We here demonstrate that graft-derived thymidine analogs can become incorporated into host neural precursors and glia. Large numbers of labeled neurons and glia were found 3–12 weeks after transplantation of thymidine analog-labeled live stem cells, suggesting differentiation of grafted cells. Remarkably, however, similar results were obtained after transplantation of dead cells or labeled fibroblasts. Our findings reveal for the first time that thymidine analog labeling may not be a reliable means of identifying transplanted cells, particularly in highly proliferative environments such as the developing, neurogenic, or injured brain.

This article has been cited by other articles:

				P. A. Walker, S. K. Shah, M. T. Harting, and C. S. Cox Jr Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation Dis. Model. Mech., January 1, 2009; 2(1-2): 23 - 38. [Abstract] [Full Text] [PDF]

				H. Reinecke, E. Minami, W.-Z. Zhu, and M. A. Laflamme Cardiogenic Differentiation and Transdifferentiation of Progenitor Cells Circ. Res., November 7, 2008; 103(10): 1058 - 1071. [Abstract] [Full Text] [PDF]

				V. Reumers, C. M. Deroose, O. Krylyshkina, J. Nuyts, M. Geraerts, L. Mortelmans, R. Gijsbers, C. Van den Haute, Z. Debyser, and V. Baekelandt Noninvasive and Quantitative Monitoring of Adult Neuronal Stem Cell Migration in Mouse Brain Using Bioluminescence Imaging Stem Cells, September 1, 2008; 26(9): 2382 - 2390. [Abstract] [Full Text] [PDF]

				S.-S. Kim, S.-W. Yoo, T.-S. Park, S.-C. Ahn, H.-S. Jeong, J.-W. Kim, D.-Y. Chang, K.-G. Cho, S. U. Kim, Y. Huh, et al. Neural Induction with Neurogenin1 Increases the Therapeutic Effects of Mesenchymal Stem Cells in the Ischemic Brain Stem Cells, September 1, 2008; 26(9): 2217 - 2228. [Abstract] [Full Text] [PDF]

				E. Pawelczyk, A. S. Arbab, A. Chaudhry, A. Balakumaran, P. G. Robey, and J. A. Frank In Vitro Model of Bromodeoxyuridine or Iron Oxide Nanoparticle Uptake by Activated Macrophages from Labeled Stem Cells: Implications for Cellular Therapy Stem Cells, May 1, 2008; 26(5): 1366 - 1375. [Abstract] [Full Text] [PDF]

				J. J Ross and C. M Verfaillie Evaluation of neural plasticity in adult stem cells Phil Trans R Soc B, January 12, 2008; 363(1489): 199 - 205. [Abstract] [Full Text] [PDF]

				K. Kamiya, Y. Fujinami, N. Hoya, Y. Okamoto, H. Kouike, R. Komatsuzaki, R. Kusano, S. Nakagawa, H. Satoh, M. Fujii, et al. Mesenchymal Stem Cell Transplantation Accelerates Hearing Recovery through the Repair of Injured Cochlear Fibrocytes Am. J. Pathol., July 1, 2007; 171(1): 214 - 226. [Abstract] [Full Text] [PDF]

				S. Almond, R. M Lindley, S. E Kenny, M G. Connell, and D. H Edgar Characterisation and transplantation of enteric nervous system progenitor cells Gut, April 1, 2007; 56(4): 489 - 496. [Abstract] [Full Text] [PDF]

				T. M. Coyne, A. J. Marcus, D. Woodbury, and I. B. Black Marrow Stromal Cells Transplanted to the Adult Brain Are Rejected by an Inflammatory Response and Transfer Donor Labels to Host Neurons and Glia Stem Cells, November 1, 2006; 24(11): 2483 - 2492. [Abstract] [Full Text] [PDF]

				U. Kunter, S. Rong, Z. Djuric, P. Boor, G. Muller-Newen, D. Yu, and J. Floege Transplanted Mesenchymal Stem Cells Accelerate Glomerular Healing in Experimental Glomerulonephritis J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2202 - 2212. [Abstract] [Full Text] [PDF]